How many tablets does a box of ibrutinib/ibrutinib contain?

Ibrutinib/Ibrutinib is a prescription drug that specifically targets certain leukemias and lymphomas. Its treatment scope covers chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL), Waldenstrom's macroglobulinemia (WM) and chronic graft-versus-host disease (cGVHD). Regarding the number of pills it contains in a box, this actually varies between drug manufacturers and product versions.

Ibrutinib has demonstrated effectiveness in slowing the progression of chronic lymphocytic leukemia, both in treatment-naïve patients and in those who have experienced other treatment options. Even more exciting is that ibrutinib has also shown significant therapeutic effects in patients with mantle cell lymphoma who have failed to respond to previous treatments or whose disease has recurred. Such patients often have a poor prognosis and limited treatment options. In addition, ibrutinib has also achieved impressive results in the treatment of Waldenström's macroglobulinemia. The drug's tolerability among patients was generally considered acceptable.

From the perspective of packaging specifications, ibrutinib presents diversified forms. For example, there may be ibrutinib products on the market that contain 28 tablets per box, and the dosage of each tablet may also be different, such as 140 mg, 280 mg, 420 mg or 560 mg. In other words, if a patient purchases this size, they will receive exactly 28 pills in a box. However, the packaging of ibrutinib is not limited to this, and there are many other specifications. For example, some versions may be 70 mg or 140 mg per capsule, and the quantity may be capsule preparations of different sizes such as 28 capsules, 90 capsules, or 120 capsules.